Fda Raises Concerns Over Phenylephrine: It Is Time To Ret...
FDA has raised significant concerns over the efficacy and safety of phenylephrine.
Dr. Robert Bocian, MD, PhD, FAAAAI (Co-Founder & Chief Scientific Officer)
Dr. Robert Bocian earned his MD and PhD at University of Illinois, Chicago, then moved to the Bay Area to complete his residency and allergy-immunology fellowship at Stanford. He has remained at Stanford for 30 years, serving as an adjunct clinical associate professor of allergy-immunology. Dr. Bocian also leads multiple allergy departments throughout Northern California at a large multi-specialty health system, including his own large Palo Alto-based practice. Dr. Bocian splits his time between Palo Alto and Los Angeles with his wife and 4 children.
Board Certifications:
Allergy and Immunology
Credentials:
Ph.D. in Microbiology and Immunology, University of Illinois, Chicago
Medical School - University of Illinois College of Medicine, Chicago
Residency - Stanford University Medical Center
Internship - Stanford University Medical Center
Fellowship - Stanford University School of Medicine
